What you missed this week on Contemporary OB/GYN


It was a very busy week for the Contemporary OB/GYN team.

This week’s top articles included:

Hormonal contraception for women with hypertension

Although hypertension is a modifiable risk factor for cardiovascular disease (CVD), certain hormonal contraceptives increase the risk of stroke and myocardial infarction in women with the disorder.

Effect on endometriosis recurrence with postoperative hormonal suppression

“As surgeons, our primary goal is to make patients feel better and we often accomplish this by surgically treating endometriosis,” said co-author Ally Murji, MD, MPH, an associate professor of ob/gyn at the University of Toronto and Mount Sinai Hospital in Toronto, Canada.

Placental DNA may predict pregnancy complications

New research suggests that placental DNA may have potential as a biomarker for adverse pregnancy outcomes (APOs).

COVID-19 Pregnancy Data in the United States: October 16 Update

Our weekly update of COVID-19 Pregnancy Data, collected by the Centers for Disease Control and Prevention (CDC), totals 26,364 cases, 45 deaths, and 6,011 hospitalizations.

Related Videos
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit: sutterhealth.org
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit: cdc.gov
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:  uofmhealth.org.
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit: uclahealth.org.
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit: mayo.edu.
raanan meyer, md
New data shows elinzanetant's efficacy in treating menopausal symptoms | Image Credit: uvahealth.com
Related Content
© 2024 MJH Life Sciences

All rights reserved.